针对发生于不同背景的肝细胞癌 (HCC) ,在肝功能允许的条件下 ,手术切除是首选的治疗方法。近年来伴随着术前诊断、外科技术的进步 ,HCC手术切除的疗效逐年上升 ,而经皮无水酒精注射 (PEIT)、肝动脉栓塞化疗 (TACE)等非手术治疗也同时呈现盛行的趋势 ,虽然其远期疗效依然不太清楚 ,但就目前来讲其适应证有着扩大的倾向。现回顾和综述HCC非手术治疗的利弊特别是近年来一些HCC的临床治疗经验及研究进展 For hepatocellular carcinoma (HCC) occurring in different backgrounds, surgical resection is the preferred method of treatment under the conditions of liver function. In recent years, along with the progress of preoperative diagnosis and surgical technique, the curative effect of surgical resection of HCC increases year by year, while the non-surgical treatment of percutaneous ethanol injection (PEIT) and hepatic arterial chemoembolization (TACE) Although its long-term efficacy is still not clear, its indications for the moment are expanding. Now reviewed and reviewed the advantages and disadvantages of non-surgical treatment of HCC, especially in recent years, some of the clinical experience and research progress of HCC